Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Documents similaires

• The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
  par: Patmanathan, S.N., et autres
  Publié: (2015)
• Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
  par: Anthony, D, et autres
  Publié: (2014)
• Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
  par: Siyao Li, et autres
  Publié: (2023-07-01)
• The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
  par: Masayo Aoki, et autres
  Publié: (2020-01-01)
• Fingolimod (FTY720) stimulates Ca(2+)/calcineurin signaling in fission yeast.
  par: Kanako Hagihara, et autres
  Publié: (2013-01-01)